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Background: The limited antibiotic options for effective control of methicillin-resistant Staphylococcus aureus infections
has led to calls for new therapeutic approaches to combat this human pathogen. An alternative approach to control
MRSA is through the use of anti-infective agents that selectively disrupt virulence-mediated pathways without affecting
microbial cell viability or by modulating the host natural immune defenses to combat the pathogen.
Methods: We established a C. elegans – S. aureus liquid-based assay to screen for potential anti-infectives against
S. aureus. The assay was utilized to screen 37 natural extracts and 29 synthetic compounds for the ability to extend the
lifespan of infected nematodes. Disc diffusion and MIC microdilution tests were used to evaluate the anti-microbial
properties of these natural extracts and synthetic compounds whilst in vivo bacterial CFU within the C. elegans gut were
also enumerated.
Results: We screened a total of 37 natural extracts and 29 synthetic compounds for anti-infective properties. The screen
successfully revealed 14 natural extracts from six plants (Nypa fruticans, Swietenia macrophylla, Curcuma longa, Eurycoma
longifolia, Orthosiphon stamineus and Silybum eburneum) and one marine sample (Faunus ater) that improved the
survival of S. aureus-infected worms by at least 2.8-fold as well as 14 synthetic compounds that prolonged the survival
of S. aureus-infected nematodes by 4-fold or greater. An anti-microbial screen of all positive hits demonstrated that
8/28 hits had no effect on S. aureus growth. Of these 8 candidates, 5 of them also protected the worms from MRSA
infection. We also noted that worms exposed to N. fruticans root and O. stamineus leaf extracts showed reduced intestinal
colonization by live S. aureus. This suggests that these extracts could possibly activate host immunity to eliminate the
bacteria or interfere with factor/s that prevents pathogen accumulation.
Conclusion: We have successfully demonstrated the utility of this liquid-based screen to identify anti-infective substances
that prolong S. aureus-infected host survival without affecting bacterial cell viability.
Keywords: S. aureus, C. elegans, Anti-infectivesBackground
Staphylococcus aureus is capable of causing a variety of
human diseases in both hospital and community settings.
Diseases caused by S. aureus range from superficial skin
infections to life threatening systemic bacteremia [1]. The
effectiveness of current antibiotic treatments that interfere
with S. aureus growth and viability is limited by the devel-
opment of drug resistance. The rapid emergence of* Correspondence: sheila@ukm.my
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reproduction in any medium, provided the orantibiotic resistant strains [2,3] highlights the urgent need
for newer and safer strategies to combat infection. An
alternative approach to overcome the pitfalls of drug re-
sistance is to develop anti-infective agents that selectively
disrupt virulence-mediated pathways without affecting
microbial cell viability [4-6] or by modulating the host
natural immune defenses to combat the pathogen [7].
A number of different strategies have been adopted to
identify new anti-infectives and these include using whole-
animal infection models such as Caenorhabditis elegans
[8-12]. Whilst traditional in vitro and whole cell drug
screens are acknowledged as the established paradigm fortd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chemical structure of butylated hydroxytoluene
(BHT) and stilbenes. (A) BHT, with its IUPAC name 2,6-bis
(1,1-dimethylethyl)-4-methylphenol, is chemical derivative of phenol
(C6H5OH) [25]. (B) and (C) refer to the two isomers of stilbene (IUPAC
name: 1,2-diphenylethene). (B) (Z)-stilbene or cis-stilbene and (C)
(E)-stilbene or trans-stilbene.
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proach allows for early and direct assessment of in vivo
drug efficacy, thus, eliminating compounds that are toxic
to the host or with poor pharmacokinetic properties [13].
As current understanding of host-pathogen interactions
and bacterial pathogenesis continues to increase [14,15],
the C. elegans model presents an advantage in being able
to simultaneously identify compounds that target bacterial
virulence as well as host defense.
In a live animal model with a recognized host-pathogen
interaction, potential hits that selectively disrupt the viru-
lence pathways utilized by pathogens to establish infections
can be identified [13,16]. Furthermore, several conserved
innate immune signaling pathways have been revealed from
studies of host-pathogen interactions using C. elegans [17].
Conceptually, anti-infectives that target nonessential genes
are likely to impose a lower level of selective pressure and
probability of resistance development [18] whilst ensuring
the preservation of host endogenous microflora.
Infection of C. elegans by S. aureus is a robust platform
to elucidate the mechanisms of host-pathogen interaction
[19-22]. In this study, our aim was to extend these studies to
the discovery of novel anti-infectives. To achieve this object-
ive, we chose to establish a C. elegans – S. aureus liquid-
based screen to identify anti-infectives that extend the lifespan
of S. aureus - infected nematodes from a collection of locally
acquired natural products and synthetic compounds.
Methods
Bacterial and nematode strains
The methicillin-susceptible S. aureus strain NCTC8325-
4 [19] and methicillin-resistant S. aureus (MRSA) strain
ATCC33591 were grown with aeration in Trypticase Soy
(TS) media (Oxoid/Pronadisa) at 37°C while Escherichia
coli strain OP50 was grown in Luria Bertani (LB) broth
supplemented with streptomycin (100 μg/mL). The wild
type C. elegans Bristol N2 hermaphrodite strain was prop-
agated on nematode growth medium (NGM) and fed on
the standard laboratory food source, E. coli OP50. The an-
imals were age-synchronized by bleaching with alkaline
hypochlorite and sodium hydroxide to release embryos.
Embryos were placed on plates containing concentrated
E. coli DH5α at 25°C until the worms reached the young
adult stage. To eliminate the confounding effects of re-
production on the scoring of surviving worms, wild type
C. elegans were made sterile by RNAi knockdown of
the pos-1 gene which resulted in worms laying unhatched
eggs [23]. The pos-1 RNAi treated worms were grown
for ~45 hrs at 25ºC until they reached young adult stage
and were ready to be used in the screen.
Preparation of extracts and compounds
A total of 18 plant species and one marine sample were
the source of the natural extracts. Extracts UE-01-1 toUE-08 were extracted according to the previously de-
scribed method [24]. Briefly, the plant materials and ani-
mal sample were collected from several locations in
Malaysia. The samples were authenticated, deposited and
catalogued with specimen voucher numbers (Additional
file 1). All samples were then air-dried, powdered and ex-
tracted with polar and non-polar solvents. Solvents were
then removed by evaporation using a rotary evaporator.
Extracts UE-09 to UE-20 (except UE-15) were prepared by
Herbal Science Pte. Ltd., a local pharmaceutical company.
In brief, the raw materials were collected and quality
assessed through a series of stringent microbial tests as
well as heavy metals test using an Atomic Absorption
Spectrophotometer (AAS). They were then dried, commi-
nuted or ground into fine powder before water-based ex-
traction was performed. The microbial and trace metal
element tests were repeated again on the yield obtained.
The finished products were examined for the presence of
certain functional groups/molecules using Fourier trans-
form infrared spectroscopy (FTIR) and High-performance
liquid chromatography (HPLC). UE-15 was purchased
from Merck, Germany.
Four different series of butylated hydroxytoluene
(BHT) derivatives (Figure 1) were designed and syn-
thesized by the Chemistry Department, University of
Malaya, Malaysia. Thiosemicarbazides were synthesized
according to the method of Yehye et al. [25,26]. 1,3,4-
thiadiazoles and 1,2,4-triazole bearing the free radical
scavenger BHT were synthesized using acid-(base-) cata-
lyzed intramolecular dehydrative cyclization reaction of
the 1-acylthiosemicarbazides whilst hydrazones were syn-
thesized from the reaction between free amino groups and
properative aldehydes (Yehye et al., in preparation). All ex-
tracts and compounds were dissolved in dimethyl sulfox-
ide (DMSO), filtered through a 0.2 μm membrane filter
and stored at −20°C. Detailed information on all natural
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provided in Additional file 2.
C. elegans survival assay
For the agar-based assay, 10 μL of a S. aureus overnight
culture in TS broth was spread on 3.5 cm TS agar plates
and incubated at 37°C for 24 hrs. The plates were then
allowed to equilibrate to room temperature for at least 1
hour before use. A total of 40 young adult worms were
transferred to the agar plate and incubated at 25°C.
Worm mortality was monitored at 24-hour intervals.
E. coli OP50 on NGM was used as the negative control.
Three independent experiments were performed.
For the liquid-based assay, a 24-well plate was filled with
S. aureus/MRSA in a liquid medium (80% M9 buffer, 20%
S. aureus overnight culture and 10 μg/mL cholesterol) and
20 synchronized young adult nematodes were transferred
into each well. Wells containing C. elegans, E. coli OP50
and M9 buffer served as the control. The total number of
worms for each treatment was 120 in six wells represent-
ing six technical replicates. The plate was incubated at
25°C and survival was monitored every 24 hrs following
exposure to the pathogen.
Anti-infective screening
Screening was performed in liquid medium in a 24-well
plate. The liquid screening medium consisted of worm
M9 buffer and overnight culture of S. aureus/MRSA in
TS broth with 10 μg/mL of cholesterol at a ratio of 4:1
(v/v). The medium was supplemented with either natural
extracts or synthetic compounds to a final concentration
of 200 μg/mL (natural extracts) and 200 μM (synthetic
compounds). All components of the assay were mixed
evenly and 500 μL of medium was transferred into each
well in a 24-well plate. In control wells, the extract
or synthetic compound was replaced with 1% DMSO or
S. aureus was replaced by E. coli OP50 as the nematode
food source. Each extract or compound was tested in
triplicate wells. Approximately 10–15 age-synchronized
pos-1 treated young adult stage N2 nematodes were
transferred into each well and the plate was incubated at
25°C. Worms treated with pos-1 RNAi produced un-
hatched eggs thereby eliminating potential complications
during the scoring of worms. Worm survival was scored
manually every 24 hrs for 5 days. In addition, turbidity
of the extract/compound containing media was also ob-
served and recorded. An extract or compound was con-
sidered a positive hit if >50% of the infected worms
survived compared to ≤ 20% survival in the untreated
control worms in least two replicates. All positive hits
from the primary screen were subjected to a secondary
screen for confirmation. A summary of the one-step
anti-infective liquid screen approach used in this study
is presented in Additional file 3 and is compared to thepreviously reported two-step agar-liquid protocol used
by Moy et al. [8] for screening of antimicrobials against
Enterococcus faecalis and high throughput liquid-based
chemical screen to screen for molecules that attenuate
Pseudomonas aeruginosa virulence and rescue C. elegans
from infection [11].
Determination of antimicrobial property by disc diffusion
assay
The disc diffusion method [27] was used to determine if
the extracts and compounds also promoted antimicrobial
features. Sterile filter paper discs (Whatman No. 1, 6 mm)
were impregnated with each of the extracts (20 mg/mL)
or compounds (20 mM) and left to dry under sterile con-
ditions overnight. S. aureus was spread evenly onto the
surface of TS agar plates using glass beads before the discs
were positioned on the inoculated agar surface. The bac-
terial inoculum size was standardized at 106 cfu/mL by
adjusting the optical density of the bacterial suspension.
DMSO served as the negative control with gentamicin
(200 μg/mL) as the positive control. All plates were
incubated for 18 hrs at 37°C. Antibacterial activity was
confirmed by the presence of a clear zone of inhibition
around the disc.
Determination of MIC and MBC
The bacteriostatic and bactericidal effects of all positive
extracts and compounds were evaluated using the broth
microdilution minimum inhibitory concentration (MIC)
assay [28]. A range of different concentrations of extract/
compound was prepared in a 48-well plate, followed by in-
oculation with 106 cfu/mL S. aureus. The plate was then
incubated at 37°C for 18 hrs. Gentamicin, the standard
antibiotic for S. aureus infections, was used as a control.
All extracts/compounds were assayed in triplicate. The
MIC endpoint recorded was the lowest concentration of
the extract/compound used in wells that showed no tur-
bidity after 18 hrs incubation, indicating an absence of
bacterial growth. The presence or absence of turbidity was
confirmed by absorption readings at 600 nm. The mini-
mum bactericidal concentration (MBC) was determined
by spreading the culture from the respective wells on ster-
ile agar plates. The MBC value was the lowest concentra-
tion of extract/compound used where no apparent growth
of bacteria was observed on the agar plate.
Enumeration of bacterial colony forming units (CFU)
within the C. elegans gut
After 24 hours exposure to S. aureus in liquid medium in
the presence and absence of extracts/compounds, 10–12
live worms were randomly picked and briefly anesthetized
in 25 mM Levamisole. The worms were washed at least
twice in 200 μL antibiotic cocktail comprising 25 mM
Lev and gentamicin 10 μg/mL followed by incubation for
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ated with the worm cuticle. Then, the worms were washed
three times with 200 μL of 25 mM Lev to eliminate the
killed bacteria and residual antibiotic. The number of
worms were recorded followed by mechanical disruption
in 50 μL of 1% Triton X (Sigma-Aldrich, USA; X100)
using a motorized pestle. Serial dilutions were performed
on the worm lysates and 10 μL of each dilution was spot-
ted on TS agar supplemented with 5 μg/mL nalidixic acid.
Colonies were counted after incubating the plates at 37°C
overnight. Bacterial CFU per worm was calculated using
the formula reported by Ooi et al. [29].
Statistical analysis
All data are presented as mean ± standard deviation (SD)
of at least two independent experiments. All screening
assays, antibacterial tests and in vivo CFU assay were rep-
licated in a comparable manner. Data from the killing as-
says were analyzed with StatView® 5.0.1 (SAS Institute,
Inc) and plotted using the Kaplan-Meier Cumulative Sur-
vival Plot for Time (nonparametric survival analysis). The
pair wise comparison was analyzed using the Log-rank
(Mantel-Cox) significance test.
Results
Liquid-based screen was able to detect more hits
Most studies on C. elegans infections by S. aureus are
routinely performed on agar plates. In this study, we ob-
served significant reduction in the lifespan of C. elegans
infected by S. aureus in both the agar-based and liquid-
based assays (Figure 2A and B). Specifically, the mean
time to death (TDmean) for S. aureus-infected animals
assayed on agar was 73 ± 1.5 hrs which was consistent
with previous studies [20]. Similarly, in the liquid-based
assay, worms in M9 buffer and S. aureus culture (4:1, v/v)Figure 2 S. aureus kills C. elegans in both liquid and agar medium. Re
strain NCTC8325-4 in (A) liquid medium consisting of 80% M9 buffer, 20% S. a
(A) shows the mean ± SD of six replicates (20 nematodes/replicate) and graph
from a representative of three independent assays.had a TDmean of 72 ± 5 hrs. S. aureus required 4 to 5 days
for complete killing of C. elegans. In liquid medium, the
worms infected by S. aureus started to die after 24 hrs ex-
posure to the pathogen. Mobility, pharyngeal pumping
and foraging rates of worms exposed to pathogens pro-
gressively decreased with time until all worms became im-
mobile and died. The results confirmed that in liquid
medium, S. aureus is able to kill the nematodes as effi-
ciently as the standard agar-based assay system.
To establish the utility of the liquid assay for anti-
infective screening, we screened a subset of 18 natural
extracts using both liquid- and agar-based assays. In the
agar-based assay, extracts were added into the TS agar
whilst the prepared agar was in a molten state. Nematode
survival on extract-added plates was compared to the con-
trol (agar without extract). Only 1/18 demonstrated poten-
tial anti-infective properties when compared to controls in
the absence of extract on solid agar (Figure 3). By contrast,
when the assay was performed in the liquid-based assay,
we were able to detect 7/18 potential hits that reprodu-
cibly extended the lifespan of S. aureus-infected worms in
at least two independent experiments (Figure 3). These re-
sults indicated that screening using a liquid-based assay
was able to detect more hits than the conventional agar-
based assay. Thus, we carried out the anti-infective screen
on the rest of the extracts and compounds using the
liquid-based screen.
Direct comparison of the hits identified from both the li-
quid and agar based screens (Figure 3) confirmed that only
UE-08 promoted the survival of infected worms in both
agar-based and liquid based screens. UE-01-1, UE-01-2,
UE-01-4, UE-01-6, UE-01-7 and UE-03-5 were able to im-
prove the lifespan of infected worms in liquid medium but
not in agar and this could be due to thermal degradation
of certain active molecules (saponins, flavonoids) duringpresentative survival curves of C. elegans following infection by S. aureus
ureus overnight culture and cholesterol and (B) TS agar medium. Graph
(B) presents the mean ± SD of three replicates (40 nematodes/replicate)
Figure 3 Liquid-based assay identified more hits than the agar-based assay. Comparison of hits from the preliminary screen of 18 natural
extracts on both agar-based and liquid-based assays. All natural extracts were tested at same concentration (200 μg/mL) in both agar and liquid
assays. The graph represents the mean percentage of survival ± SD at 72 hours post-infection of three replicates from a representative of two
individual experiments. The survival of extract-treated worms is compared to the control (no extract). (*) indicates positive in agar-based screens
while (**) indicates positive in liquid-based screens.
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the solid agar and liquid-based screens are elaborated in
Table 1.
Selected extracts and compounds enhanced the survival
of S. aureus-infected nematodes
We performed a small scale screen in 24-well plates
using the S. aureus – C. elegans liquid infection assay to
identify more potential anti-infectives that improved the
survival of infected worms. Screening over 37 natural
plant and marine invertebrate extracts and 29 synthetic
compounds revealed a total of 14 natural extracts and
14 synthetic compounds that conferred increased sur-
vival of S. aureus-infected nematodes (Figure 4). The cri-
teria adopted to classify an extract or compound as a
positive hit was the survival of >50% of the infected
worms compared to ≤ 20% survival in untreated wells
over at least two replicates. All positive hits contributed
to more than 60% C. elegans survival following infection
and treatment for 72 hrs compared to about 20% sur-
vival in untreated controls (Table 2). All positive natural
extracts increased nematode survival by 2.8-fold or more
while all positive synthetic compounds exhibited a more
significant increase in survival of at least 4-fold. TheTable 1 Comparison between agar-based versus liquid-based
Criteria Agar-based
Positive hits identified 1 out of 18 natural extracts screen
Average time for media preparation 2-3 days
Possibility of compound degradation Addition of compound into the m
temperature may cause compoun
Exposure to compound Compound is restricted to the aga
in limited worm exposure to the c
Counting efficiency Time-consuming to locate the wo
surface area
Possible agar color changes comp
The advantages of the liquid-based screen developed are listed along with the limiworms fed on E. coli OP50 remained alive throughout
the assay. Detailed information on all positive hits is
shown in Table 2.
The striking differences in the appearance of live
worms and worms that succumbed to infection facili-
tated the screening process. The infected worms were
generally smaller in size as compared to healthy worms
fed on E. coli OP50. Dead worms did not move or ex-
hibit muscle tone and did not respond to external stim-
uli. They appeared as straight rigid rods in the medium
with no observable pharyngeal pumping (Figure 5A). In
contrast, worms exposed to E. coli OP50 maintained a
sinusoidal ‘S’ shape and moved actively. These worms
grew in size and developed into gravid adults which pro-
duced eggs (Figure 5B). With the addition of extract/
compound that exhibited potential anti-infective proper-
ties, the worms were rescued from the S. aureus in-
fection as demonstrated by their ability to overcome
the debilitating effects of the infection. As indicated in
Figure 5C, the surviving infected nematodes appear to
be smaller in size, similar to that of the untreated in-
fected worms. Nevertheless, the live worms were able to
maintain the sinusoidal ‘S’ shape posture and respond to
external stimuli when touched. In addition, the wormsscreens
Liquid-based
ed 7 out of 18 natural extracts screened
<30 minutes
olten agar at high
d degradation
Does not involve high temperature. Thus,
degradation of compound is not possible
r media, resulting
ompound
Worms are bathed in a homogenous
solution of compound
rms on a larger Smaller surface area and clear distinguishable
phenotype of the worms allows quick scoring
licate worm scoring Colorless M9 buffer eases the scoring of worms
tations of an agar-based assay.
Figure 4 Extracts and compounds rescued the worms from a S. aureus infection. Percentage of survival for S. aureus-infected nematodes
upon exposure to extracts (200 μg/mL) and compounds (200 μM) in the primary anti-infective screen. The graph depicts the percentage of survival at
72 hours post-infection when the assay was carried out in the absence of presence of different extracts/compound. Results are expressed as
mean ± SD from a representative of at least two individual assays. Dashed lines show the percentage of survival for untreated worms (no extract/no com-
pound) while straight lines demarcate the positive hits. Extracts and compounds that contributed to > 50% infected worm survival were considered as
positive in the primary screen.
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S. aureus. Although the worms were able to survive
upon S. aureus infection in the presence of hit extracts/
compounds, most of the live worms appeared to expe-
rience delayed development as compared to healthy
worms fed on E. coli OP50.
Among 18 plant species tested, extracts from six
plants (N. fruticans, S. macrophylla, C. longa, E. longifo-
lia, O. stamineus and S. eburneum) were able to extend
the lifespan of S. aureus-infected animals. The marine
sample (F. ater) also possessed potential anti-infective
activity. N. fruticans, S. macrophylla, C. longa, E. longifo-
lia and O. stamineus are commonly found in Malaysia
and used widely by the local community as folk medi-
cine. Hence, local traditional herbs are a promising
source of largely unexplored classes of anti-infectives.
We tested seven samples from N. fruticans obtained
from different parts of the plant through the use of
different extraction solvents. Our screen identified 5/7
N. fruticans samples that increased the survival of in-
fected nematodes by 2.9 to 3.7 fold. Different parts of
the plant, for example, leaves, roots and husks, may
contain different sets of bioactive compounds whilst
the different extraction solvents used may also separate dif-
ferent bioactive constituents. Alternatively, the differencesmay be due to variations in the quantity of the individ-
ual active components in these tissues. Both C. longa
and curcumin showed an equally strong effect by en-
hancing the survival of S. aureus-infected nematodes by
at least 4-fold (Table 2). Curcumin is the main active
ingredient in C. longa suggesting that curcumin might be
the contributing bioactive component of C. longa. Metha-
nol, butanol and ethyl acetate extracts of S. macrophylla
were also able to prolong the lifespan of S. aureus-infected
worms with the butanol extract showing the most en-
hanced effect, whereby worm survival increased by 4.2-
fold. Of all the extracts tested, the S. macrophylla butanol
extract, curcumin and S. eburneum seed extract demon-
strated very promising anti-infective activity by promoting
the survival of S. aureus-infected worms by more than
4-fold.
With the synthetic compounds, all 14 hits promoted
the survival of infected worms by at least 4-fold with
UC-15, UC-16, UC-27 and UC-28 demonstrating the
most prominent effect, whereby worm survival increased
by 5-fold. Compounds UC-01, UC-02 and UC-03 are
variations of thiosemicarbazide, UC-07, UC-08, UC-09,
UC-10, UC-11 and UC-12 were synthesized based on of
1,2,4-triazole-5-thiones, UC-15 and UC-16 are derived
from hydrazones, UC-27 and UC-28 are stilbene derivatives
Table 2 Natural extracts and synthetic compounds that promote survival of S. aureus-infected nematodes
No. Extract/compound ID Plant/animal species Extraction solvent Mean % of survival Fold change survival vs. untreateda
1 UE-01-1 Nypa fruticans husks Methanol 76.7 3.3
2 UE-01-2 N. fruticans leaves Hexane 78.4 3.4
3 UE-01-4 N. fruticans roots Butanol 84.2 3.7
4 UE-01-6 N. fruticans roots Chloroform 67.3 2.9
5 UE-01-7 N. fruticans leaves Chloroform 83.3 3.6
6 UE-02-4 Faunus ater Methanol 63.3 2.8
7 UE-03-3 Swietenia macrophylla seeds Methanol 70.0 3
8 UE-03-5 S. macrophylla seeds Ethyl acetate 65.0 2.8
9 UE-03-6 S. macrophylla seeds Butanol 96.7 4.2
10 UE-08 Curcuma longa Water 93.3 4
11 UE-11 Eurycoma longifolia roots Water 73.0 3.2
12 UE-12 Orthosiphon stamineus leaves Water 71.8 3.1
13 UE-15 Curcumin - 100.0 4.3
14 UE-18 Silybum eburneum seeds Water 100.0 4.3
15 UC-01 - - 90.0 4.5
16 UC-02 - - 86.7 4.3
17 UC-03 - - 80.0 4
18 UC-06 - - 80.0 4
19 UC-07 - - 90.0 4.5
20 UC-08 - - 90.0 4.5
21 UC-09 - - 96.7 4.8
22 UC-10 - - 86.7 4.3
23 UC-11 - - 96.7 4.8
24 UC-12 - - 96.3 4.8
25 UC-15 - - 100.0 5
26 UC-16 - - 100.0 5
27 UC-27 - - 100.0 5
28 UC-28 - - 100.0 5
aNote that ~20% of the untreated worms survived 72 hours post-infection. The mean percentage of survival from one representative biological replicate out of
three independent assays is presented.
Figure 5 Distinct appearances of dead and alive C. elegans. Representative micrographs of C. elegans exposed either to S. aureus (A), E. coli
OP50 (B) or S. aureus in the presence of extracts/compounds (C). The worms were examined under a stereomicroscope (Nikon SMZ645) at a
magnification of x40. White arrows denote the worms.
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ception of stilbene, all other compounds were fused to a
BHT moiety. The structures of all 14 positive synthetic
compounds are shown in Figure 6.
As illustrated in Figure 7, different extracts/compounds
exhibited different degrees of protection in extending theFigure 6 Structure of the compounds that promoted the survival of S
are thiosemicarbazides, UC-06 is 1,3,4-thiadiazoles, UC-07, UC-08 and UC-09
benzylideneamino-1,2,4-triazole-5-thiones, UC-15 and UC-16 are hydrazone
the exception of the stilbene derivatives, are fused to a BHT moiety.lifespan of nematodes following S. aureus infection. During
the screening process, we also took note of changes
in media turbidity indicative of bacterial presence and
growth. Upon addition of selected extracts and compounds,
for example UE-08 and compound UC-15, into the
medium, a significant clearing of the medium was noted.. aureus infected nematodes. Compounds UC-01, UC-02 and UC-03
are 1,2,4-triazole-5-thiones, UC-10, UC-11 and UC-12 are 4-(substituted
s and UC-27 and UC-28 are stilbene derivatives. All compounds, with
Figure 7 Survival of C. elegans is improved over time upon supplementation of extracts and compounds. (A and B) The survival curves
of S. aureus-infected C. elegans upon exposure to selected hit extracts (200 μg/mL) and compounds (200 μM). Enhanced survival of infected
worms can be seen in the presence of extracts UE-01-2, UE-03-5, UE-08 (A) and compounds UC-10, UC-12 and UC-15 (B). Data at each time point
are the average of three wells with each well containing approximately 10–15 animals per well. In a pair-wise comparison to no extract using
log-rank tests, the difference between all of the treatments was significant (p < 0.0001).
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results of all positive hits as shown in Table 3, we noted
that extract UE-08 and compound UC-15 possessed strong
antibacterial activity against S. aureus. The survival curves
presented in Figure 7A and B reflect that both these hits
exerted a strong protective effect on the worms and ~100%
of worms were rescued from the lethal infection through-
out the experiment (over 5 days). Based on this, we propose
that UE-08 and UC-15 extend the lifespan of worms during
a S. aureus infection through their antimicrobial activity
against S. aureus.
In contrast, upon supplementation of the other selected
extracts and compounds into the screening media, we ob-
served a cloudy appearance (similar to the untreated con-
trol) of the media indicating continued bacterial growth.
We confirmed our observations by measuring the turbid-
ity at 600 nm. Nevertheless, addition of these extracts and
compounds significantly delayed the killing of worms by
S. aureus. Data for lifespan extension by representative
hits (extracts UE-01-2 & UE-03-5 and compounds UC-10
& UC-12) that exhibited this phenomenon are presented
in Figure 7. All these hits either did not kill S. aureus or
only inhibited S. aureus growth at very high concentra-
tions (Table 3). As they did not affect S. aureus viability
at the tested concentrations, we propose that extracts
UE-01-2 & UE-03-5 and compounds UC-10 & UC-12 en-
hance the survival of S. aureus-infected worms using other
distinct mechanisms such as reducing bacterial virulence
and/or by enhancing host immunity.
Positive hits exhibited different anti-S. aureus activity
The disc diffusion assay and MIC test were used to evalu-
ate the positive hits obtained from the anti-infective screen
for their ability to inhibit S. aureus growth. The disc diffu-
sion assay detected two natural extracts (UE-08 & UE-15)
and four synthetic compounds (UC-01, UC-15, UC-27
and UC-28) out of 28 positive hits, with antibacterial effecton S. aureus (Figure 8). To further validate the hits, we
performed the broth microdilution MIC test to obtain
both MIC and MBC values.
The respective MIC and MBC values of all 28 positive
hits in standard medium (TS broth) and screening
medium (20% TS broth + 80% M9 medium) are presented
in Table 3A and B. The negative control (DMSO) and
positive control (gentamicin) were run in parallel with a
recorded MIC for gentamicin towards S. aureus at 1.2 μg/
mL and MBC of 2.4 μg/mL. As the clearing of the liquid
medium has been used as a criterion during the anti-
infective screening, we also performed the MIC microdilu-
tion test using the screening medium. We found relatively
similar values for both media tested. Of the positive hits
screened, two natural extracts (UE-01-1 and UE-08) were
found to inhibit S. aureus growth at a concentration of
< 200 μg/mL while six compounds (UC-01, UC-07, UC-
11, UC-15, UC-27 and UC-28) exhibited bacteriostatic ef-
fects at a concentration of ≤ 200 μM. Of note is compound
UC-15, the most potent antimicrobial agent which sup-
pressed S. aureus growth at concentrations less than
62.5 μM in both standard medium and screening medium.
In the anti-infective screens discussed above, both 200 μg/
mL natural extracts and 200 μM synthetic compounds
were the working concentrations used. A further five
natural extracts (UE-01-2, UE-01-6, UE-01-7, UE-15 and
UE-18) and seven synthetic compounds (UC-02, UC-03,
UC-06, UC-08, UC-09, UC-12 and UC-16) affected S. aureus
growth in vitro but at ~ 2-fold higher concentrations
than that used in the screen. Interestingly, seven natural
extracts (UE-01-4, UE-02-4, UE-03-3, UE-03-5, UE-03-6,
UE-11 and UE-12) and one synthetic compound (UC-10)
which enhanced the survival of S. aureus-infected nema-
todes, did not exhibit any bacteriostatic or bactericidal
activity on S. aureus growth in vitro. Collectively, the
C. elegans model-based screen identified eight hits (29%)
that inhibited S. aureus growth at concentrations lower
Table 3 In vitro MIC and MBC values of all positive extracts (A) and compounds (B) against S. aureus
(A) No. Extract ID Standard medium (TS broth) Screening medium (20% TS broth + 80% M9)
Concentration (μg/mL) Concentration (μg/mL)
MIC MBC MIC MBC
1 UE-01-1 <125 1000 <125 500
2 UE-01-2 2000 - 2000 -
3 UE-01-4 - - - -
4 UE-01-6 2000 - 2000 -
5 UE-01-7 1000 2000 500 2000
6 UE-02-4 - - - -
7 UE-03-3 - - - -
8 UE-03-5 - - - -
9 UE-03-6 - - - -
10 UE-08 <125 <125 <125 <125
11 UE-11 - - - -
12 UE-12 - - - -
13 UE-15 1000 2000 500 2000
14 UE-18 1000 - 500 -
(B) No. Compound ID Standard medium (TS broth) Screening medium (20% TS broth + 80% M9)
Concentration (μM) Concentration (μM)
MIC MBC MIC MBC
1 UC-01 125 500 125 500
2 UC-02 2000 2000 2000 2000
3 UC-03 2000 2000 1000 2000
4 UC-06 2000 2000 1000 2000
5 UC-07 200 1000 125 1000
6 UC-08 1000 2000 1000 2000
7 UC-09 2000 2000 1000 2000
8 UC-10 - - - -
9 UC-11 200 - 200 -
10 UC-12 1000 - 1000 -
11 UC-15 <62.5 <62.5 <62.5 <62.5
12 UC-16 2000 - 1000 -
13 UC-27 200 200 200 200
14 UC-28 200 200 200 200
The negative (DMSO) and positive controls (gentamicin) were run in parallel in all replicates. The MIC of gentamicin towards S. aureus was 1.2 μg/mL and MBC
was 2.4 μg/mL.
MIC, minimum inhibitory concentration and MBC, minimum bactericidal concentration.
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pressed S. aureus growth at concentrations at least two-
fold higher than the screen concentrations and eight hits
(29%) that had no effect on S. aureus growth in vitro even
though they were effective in curing the worms from
infection.
Both C. longa and curcumin demonstrated anti-S. aureus
properties at different concentrations with C. longa inhibit-
ing S. aureus growth at a lower concentration (<125 μg/mL)
than curcumin (500 μg/mL). This suggests that the C. longaextract may contain multiple bioactive compounds that tar-
get S. aureus. Out of five N. fruticans positive samples, 4 of
5 were capable of inhibiting S. aureus growth with the husk
methanol extract exhibiting the strongest activity.
All synthetic compounds, with the exception of UC-10,
demonstrated antibacterial activity towards S. aureus at
different concentrations. A comparison between all 14 hits
and antibiotics currently used in a clinical setting did not
reveal any structural relationship. However, some of the
variants from these groups of compounds have previously
Figure 8 Inhibition of S. aureus growth by extracts and compounds. The clear zone formed around the discs indicated that S. aureus was
susceptible to extract UE-08 (A) and compounds UC-27 & UC-28 (B). The negative control (DMSO) showed no clear zone around the disc while
the positive control (200 μg/mL gentamicin) suppressed the growth of S. aureus and formed a 20 mm zone of inhibition around the disc.
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and UC-03 are thiosemicarbazides with different elements
attached to different positions of the second benzene ring
and thiosemicarbazide derivatives have known antimi-
crobial and antifungal properties [30,31]. Derivatives of
thiadiazoles and triazole-thiones (UC-06, UC-07, UC-08,
UC-09, UC-11 and UC-12) also showed an inhibitory
effect towards S. aureus at concentrations ranging from
200 – 2000 μM. Compounds containing a 1,3,4-thiadia-
zole nucleus and 1,2,4-trizole-thiones have a wide range of
pharmacological activities including potential antimicro-
bial properties [32,33]. On the other hand, hydrazone de-
rivatives are also active against S. aureus and P. aeruginosa
[34]. Natural stilbenes are typical plant metabolites (e.g.
resveratrol in grapes) which play a role in defending the
host against microbial attack [35]. Stilbene variants such
as hydroxystilbene and isopropylstilbene are potential
antimicrobials and show a synergistic effect when applied
together with antibiotics to inhibit and kill bacteria [36].
Our data consistently demonstrated that both stilbene
derivatives (UC-27 and UC-28) showed bactericidal effect
towards S. aureus at 200 μM. Despite ample evidence indi-
cating the antimicrobial activity of the derivatives of these
compounds, the exact mechanism on how these molecules
inhibit/kill bacteria remains unknown.
Positive hits also rescued worms from MRSA infection
From the anti-infective screen and antimicrobial suscepti-
bility test, we identified seven natural extracts (UE-01-4,
UE-02-4, UE-03-3, UE-03-5, UE-03-6, UE-11 and UE-12)
and one synthetic compound (UC-10) which significantly
increased survival of infected nematodes without affecting
S. aureus replication. The S. aureus strain NCTC8325-4
used in the screen is a methicillin-sensitive S. aureus
(MSSA) [37]. To further explore the potency of these eight
candidates, we extended our study by determining their
ability in promoting the survival of MRSA-infected worms.As the susceptibility of C. elegans towards MRSA strain
ATCC33591 has not been studied before, we performed
the survival assay in liquid medium to assess the virulence
of this MRSA strain towards wild-type C. elegans. Our re-
sults showed that MRSA ATCC33591 killed all nematodes
after 5 days post-infection with a TDmean of 68 ± 3.2 hrs
which is comparable to the MSSA strain NCTC8325-4
(Figure 9A). Interestingly, when we evaluated the eight
hits from the MSSA screen, 5/8 were also able to rescue
the worms from MRSA infection. The five natural extracts
that significantly promoted the survival of MRSA-infected
nematodes after 72 hours infection were UE-01-4, UE-03-3,
UE-03-5, UE-03-6 and UE-12 (p < 0.005). All five extracts
contributed to more than 70% C. elegans survival upon
MRSA infection compared to almost 80% death of un-
treated worms (Figure 9B). Specifically, the five extracts that
protected the worms from both antibiotic-sensitive and
antibiotic-resistant S. aureus infection were extracted from
N. fruticans roots, S. macrophylla seeds and O. stamineus
leaves.
The survival of MRSA-infected nematodes exposed to
UE-02-4, UE-11 and UC-10 was less than 40% (Figure 9B)
indicating that these three hits were only efficacious for
MSSA but not MRSA infections. Based on this, we suggest
that these compounds may be able to render the antibiotic-
sensitive strain less virulent but not the antibiotic-resistant
strain. It was possible that these hits function as a specific
inhibitor of virulence determinants that are complex and
strain specific.
Two natural extracts caused reduction in intestinal
bacterial loads
The killing of C. elegans by S. aureus is correlated with
the ability of the bacteria to colonize the worm intestine
[20]. S. aureus do not persist in the host, yet when the
host has been in contact with the bacteria for an
adequate period of time, death is observed. Similarly,
Figure 9 Nematodes infected by MRSA are rescued by natural extracts. (A) Kinetics of the killing of C. elegans by MRSA ATCC33591, S. aureus
NCTC-8325-4 and E. coli OP50 in liquid medium. Graph shows the mean ± SD of six replicates (20 worms / replicate) from a representative of three
independent experiments. (B) Survival rate of MRSA-infected nematodes upon exposure to selected extracts (200 μg/mL)/compound (200 μM). Graph
shows the percentage of survival at 72 hours post-infection when the assay was carried out without any treatment or treatment with different extracts/
compound. Results are expressed as mean ± SD from a representative of two individual assays. (**) denotes significant difference in percentage of
survival between untreated (no extract) and treated animals (p < 0.005).
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the worm intestinal lumen but do not persist within the
host [38]. To address the question of whether the level
of live S. aureus in the worm intestine remained the
same in the presence of extracts, we measured the number
of bacteria by performing a CFU assay. In vivo CFU
counts were enumerated at 12 and 24 hours when >70%
of the infected non-treated population remained alive. For
this assay, we tested the eight hits that showed no interfer-
ence with S. aureus viability in the antimicrobial test.
In the absence of extract, S. aureus grossly colonized the
worm intestine and the in vivo CFU counts for S. aureus-
infected worms was 6.25 × 104 bacteria per worm after 24
hours exposure to the pathogen. This result is consist-
ent with the data reported for worms exposed to PA14,
where the bacterial CFU counts can reach up to 103-105
bacteria per worm [29]. Upon supplementation with
extract UE-01-4 and UE-12, we observed a significant
reduction in the number of bacteria harvested from the
C. elegans intestine, 2.5 × 102 and 2.3 × 102 CFU/worm
respectively (p < 0.0001) (Figure 10). One possible ex-
planation for this is that the ingestion of bacteria is
abated as a consequence of reduced feeding following
exposure to a specific bioactive molecule. We tested this
hypothesis by counting the pharyngeal pumping rate of
the worms in the presence of UE-01-4, as an indirect
measure of the intake of bacteria. In the presence of
UE-01-4, pharyngeal pumping rates were similar to un-
treated worms (Additional file 4). Hence, suffice to say,
the low number of intestinal bacteria is not a con-
sequence of a decrease in bacteria consumption, but
rather, due to other in vivo factor/s that suppress the
number of bacteria in the host intestine. For the other five
extracts (UE-02-4, UE-03-3, UE-03-5, UE-03-6, UE-11)
and compound UC-10, we did not observe any significantdifference in the intestinal bacterial loads compared to the
untreated animals.
The extracts from N. fruticans root (UE-01-4) and
O. stamineus leaves (UE-12) limited the number of
S. aureus in the host intestine, suggesting that the mode
of action of these extracts likely involved activation of
host immunity to reduce the bacterial numbers and thus
clear the infection. For extracts UE-02-4, UE-03-3, UE-03-5,
UE-03-6, UE-11 and compound UC-10, the manifest-
ation of a healthy worm population that remained
colonized by S. aureus proposed that these extracts/
compound might have rendered the bacteria less viru-
lent and therefore harmless. The less virulent bacteria
continued to colonize the host intestine but were unable
to bring about death of the host. Alternatively, they may
have also modulated the host response to tolerate
chronic innocuous intestinal colonization. Both protect-
ive outcomes (healthy worms with harmless infection or
healthy worms with cleared infection) may arise from
either impairing the bacterial virulence or upregulating
the host defenses.
Discussion
We have successfully established a liquid-based C. elegans -
S. aureus anti-infective screen platform which is relatively
easy to perform, time-efficient and easily adaptable for
large-scale screening of compounds of interest. This
simple live animal screen enabled us to identify 14
natural extracts (from eight different plants and one
marine sample) and 14 synthetic compounds that sig-
nificantly extended the survival of S. aureus-infected
worms. We also observed that five of the selected
natural extracts conferred a survival advantage for nem-
atodes infected by MRSA. In agreement with previously
reported findings [8,9], our results demonstrate that this
Figure 10 Extracts suppressed the number of in vivo S. aureus in infected animals. Bacterial CFU in the intestine of S. aureus-infected
worms were enumerated at 24 hours post-infection in the presence and absence of extracts/compound. All extracts were tested at 200 μg/mL
and compound was tested at 200 μM. The bars correspond to mean ± SD of the number of CFU per worm from one representative of two
independent replicates. (**) marks the significant difference of in vivo CFU counts between untreated (no extract) and treated worms (p < 0.0001).
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properties, but also hits that do not affect bacterial rep-
lication in vitro which are usually overlooked in trad-
itional in vitro cell-culture based screens.
We noticed the S. aureus- infected worms under both
treated and untreated conditions appear smaller in size,
similar to previously reported observations on solid-
medium [22]. It is less likely that the small size of
infected-worms is a result of starvation as shown by
previous transcriptome analysis on fasting-response
genes [22]. The smaller size of the infected worms may
be a consequence of energy conservation and delayed
development to compensate for the effort in fighting
off the infection. Unlike the uninfected population fed
on E. coli OP50, we observed that the surviving in-
fected worms in the presence of most hits were also
small in size and slow in development. As indicated in
the antimicrobial tests, most of the positive hits did not
interfere with the growth of bacteria at the concentra-
tion used in anti-infective screening (200 μg/mL). Due
to the continuous exposure to pathogen in the screen-
ing medium, it is not surprising that the live worms re-
sembled the phenotype of infected worms, instead of
the phenotype of healthy worms fed on their natural
food source.
In contrast to Salmonella typhimurium that persist-
ently colonizes and proliferates in the nematode gut
[39], S. aureus causes transient infection and continuous
exposure up to a certain period of time is necessary to
achieve maximal worm killing. S. aureus can grossly
colonize and distend the worm intestinal lumen but does
not persist within the infected host [20]. Therefore, we
modified the method of Moy et al. [8] by exposing
worms to live bacteria throughout the assay. A similar
approach where the worms were not pre-infected has been
used to screen a small molecule library for compounds thatalleviate P. aeruginosa-mediated killing [11]. In addition,
we were able to simultaneously evaluate compounds or ex-
tracts that inhibit bacterial growth and promote host sur-
vival by observing the turbidity of the liquid medium. This
in turn, enables a quick selection of hits that do not affect
bacterial proliferation yet enhance host survival, which will
likely yield alternative therapeutics that circumvent bacter-
ial resistance and potentially overcome the limitations of
traditional antibiotics.
Among the 28 molecular entities that protected
C. elegans from lethal infection by S. aureus, seven
natural extracts and 13 synthetic compounds contain
antibacterial properties against S. aureus at different
concentrations. As expected, both C. longa and curcu-
min were able to inhibit S. aureus growth as previously
described [40,41]. On the other hand, S. macrophylla
leaves were previously reported to be active against
S. aureus [42] but we show that the seed extracts did
not affect S. aureus growth. Notably, some extracts and
compounds demonstrated antibacterial effect at very
high concentration (MIC: 2000 μg/mL). Although they
are potentially interesting as ‘probe’ molecules, these
compounds have limited potential for commercial drug
development in their current form.
Of all synthetic compounds tested, 24/29 contain a
BHT moiety (Figure 1) in their chemical structure [25].
Since the compounds tested are related to this structure,
it is not surprising that the hit rate was high among the
synthetic compounds. However, these hits do exhibit dif-
ferent activities suggesting that they may have multiple
targets, some of which are not in common and to which
they exhibit differential affinity. Up to 13/14 of the hits
demonstrated either bacteriostatic or bactericidal effects
against S. aureus at different concentrations. BHT is a
phenolic antioxidant which consists of a hydroxyl group
(−OH) bonded directly to an aromatic hydrocarbon
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ical scavenging anti-oxidant activity as BHT have been
reported to have good antibacterial and antifungal activ-
ity [43,44]. Phenolic compounds have also been reported
to exhibit antibacterial activity towards gram positive and
gram negative bacteria [45,46]. The mechanism thought to
be responsible for phenolic toxicity to bacteria includes
forming hydrogen bonds with vital proteins such as micro-
bial enzymes [47]. Thus, the anti- S. aureus property of all
the synthetic compounds tested in this study may be associ-
ated with the presence of the phenolic moiety in the BHT
chemical structure. Moreover, the backbone structures of
the compounds (thiosemicarbazides, thiadiazoles, triazole-
thiones and hydrazones) have been reported to possess
antimicrobial activity against both gram positive and nega-
tive bacteria [31,32,34]. This is believed to be able to elevate
the antimicrobial properties of these compounds.
Among all synthetic compound hits, UC-10 appeared
to be particularly interesting as it rescued the infected
worms without affecting S. aureus growth. UC-10 is a
derivative of 4-(substituted benzylideneamino)-1,2,4-tri-
azole-5-thione. In terms of structure, UC-10 differs
from UC-11 and UC-12 at the second benzene ring, at
which a –OH group was substituted at the ortho pos-
ition. The different activity of this compound, as com-
pared to the rest of the compounds, may be attributed
to the presence of this additional –OH group and two
butyl groups, resulting in two –OH groups flanking by
tert-butyl groups into one structure (Figure 6). Modifi-
cation of this aromatic ring diminished the antibacterial
property of the 4-(substituted benzylideneamino)-1,2,4-
triazole-5-thiones compound fused to the BHT moiety.
Unexpectedly, this has resulted in its ability to rescue
the infected host via a distinct mechanism, probably by
targeting bacterial virulence or host immunity.
Some extracts and compounds were able to promote
nematode survival at concentrations much lower than
their respective MIC values. The identification of seven
extracts and one compound that do not interfere with
bacteria replication suggests that this group of sub-
stances may apply non-conventional strategies to permit
host survival whilst not affecting cell viability. These
compounds may attenuate bacterial factors essential for
infection such as virulence determinants involved in host
damage and disease [4]. Additionally, some of these sub-
stances could modulate host responses towards the
pathogen [48] or act as an immunostimulator [49] that
induces the host immune defense to get rid of infection.
One of the most significant findings is the three differ-
ent extracts from S. macrophylla seed (UE-03-3, 03–5,
03–6) that prolonged the survival of both S. aureus and
MRSA-infected nematodes without diminishing the degree
of S. aureus accumulation in the C. elegans gut. A similar
effect was demonstrated in the study by Dharmalingamet al. [24] where the ethyl acetate extract (UE-03-5) also
protected C. elegans from a lethal P. aeruginosa infection
without affecting bacterial viability and in vivo proliferation
of PA14 [24]. The fact that this extract permitted the sur-
viving host to harbor a substantial bacterial load in the gut
following infection by S. aureus and P. aeruginosa indicates
that this extract might have attenuated a bacterial virulence
factor or pathway which is common among pathogens.
Hence, the anti-infectives identified using the C. elegans
screen may be multifunctional and able to target a broad
range of human pathogens. With the existence of universal
virulence strategies employed by different pathogens and
the conservation of innate immunity across phyla, anti-
infective screening using the C. elegans model has the po-
tential to identify hits that are efficacious against different
groups of pathogens.
Interestingly, extracts from N. fruticans (UE-01-4) and
O. stamineus (UE-12), plants widely found in South East
Asia, both demonstrated good anti-infective effects. Al-
though the mangrove palm is well-known for its trad-
itional use by the local practitioners to treat different
ailments in Asia, the pharmacological effect of N. fruticans
remained poorly defined until 2011 when a group from
Bangladesh reported that the leaf and stem of N. fruticans
exhibited anti-hyperglycemic and antinociceptive activities
in a mouse model [50]. On the other hand, O. stamineus
leaf extract is widely used as an herbal remedy for kidney
and urinary tract disorders. Previous studies revealed the
anti-oxidant [51,52], anti-apoptotic [51], hepatoprotective
[52] and gastroprotective [53] properties and also identi-
fied the major active fractions include eupatorin, sinen-
setin, 3′-hydroxy-5, 6, 7,4′-tetramethoxyflavone [54] and
rosmarinic acid [55]. N. fruticans and O. stamineus ex-
tracts enabled the host to survive both antibiotic-sensitive
and antibiotic-resistant S. aureus infection without inter-
fering with bacterial viability, suggesting that these ex-
tracts possess compounds capable of targeting the host
defense mechanism or attenuating bacterial virulence
traits. The fact that the intestinal colonization of S. aureus
was blocked after exposure to these extracts further con-
solidates the possibility that these compounds enhance the
host immunity to eliminate the pathogen or target the
bacteria factor/s that prevent them from accumulating in
the intestine . Therefore, extracts UE-01-4 and UE-12 are
potential anti-infective candidates that may act by target-
ing the host immune defenses. Further investigations are
ongoing to identify the active compound/s that actively
promotes lifespan extension in S. aureus-infected nema-
todes and the potential anti-infective underlying mechan-
ism(s) of these candidates.
Not surprisingly, a small number of compounds accel-
erated the killing of nematodes by S. aureus. When the
worms were exposed to these substances and fed with
heat-killed E. coli OP50, a significant decrease in survival
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pared to the untreated control implying that the sub-
stance is toxic to the host (Additional file 5). Hence, by
using this C. elegans screen, we are able to filter com-
pounds that exhibit toxicity upon the host [56].
Conclusion
The results of the present study demonstrate the ability
of this liquid-based screen to identify anti-infective sub-
stances that enhance host survival without interfering
with bacterial viability. There is an ever-growing list of
Gram-positive, Gram-negative and fungal pathogens
that are known to infect C. elegans, many of which are
of clinical relevance. With minor modifications and
optimization, this platform can be adapted to screen
for novel therapeutic agents against infectious agents.
Furthermore, by utilising readily available mutant and
reporter worm strains, the mechanism of action associ-
ated with the increased survival upon treatment can be
further investigated.
Additional files
Additional file 1: The source and voucher number of plant
materials/marine sample for all extracts provided by the Institute
for Pharmaceuticals and Neutraceuticals Malaysia (IPharm) and
Universiti Malaysia Terengganu.
Additional file 2: Detailed information of all natural extracts and
synthetic compounds used in the anti-infective screening.
Information of all natural extracts and synthetic compounds were
presented along with the results summary of disc diffusion assay and
MIC test.
Additional file 3: Screening protocol. (A) Summary of the anti-
infective liquid screen towards S. aureus in a C. elegans model used in this
study, (B) the combination agar-liquid screen protocol used by Moy et al.
[8] to screen for antimicrobials towards E. faecalis in a C. elegans model
and (C) the high-throughput liquid-based chemical screen to screen for
compounds that attenuate P. aeruginosa virulence and rescue C. elegans
from infection [11].
Additional file 4: Extract UE-01-4 had no effect on the pharyngeal
pumping rate of the infected worms. The pharyngeal pumping rates
of S. aureus-infected nematodes upon treatment with UE-01-4 (200 μg/
mL) were enumerated and compared to the untreated control. The bars
correspond to mean ± SD of the pharyngeal pumps/second from one
representative of two individual replicates. No significant difference in the
pumping rates between the treated and untreated worms (p > 0.005) was
observed.
Additional file 5: Representative compounds that were toxic
towards nematodes. Survival curves of C. elegans fed on heat-killed E. coli
OP50 in the presence of two selected compounds at 200 μg/mL. Survival of
OP50-fed worms reduced significantly upon exposure to UC-13 and UC-24
(p < 0.0001). The graph shows the mean ± SD of three replicates
(10–15 animals) from a representative of two independent assays.
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